Skip to search formSkip to main contentSkip to account menu

HTLV I p53 Ab:PrThr:Pt:Ser:Ord

Known as: HTLV 1 p53 Ac:ACnc:Pt:Soro:Ord, ???? 1 p53 ??:PrThr:??????:???:???, HTLV1 p53 Ac Ser Ql 
National Institutes of Health

Related topics

Related topics

5 relations
AntibodiesHuman T-lymphotropic virus 1Microbiology procedureSerum

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity
A widespread decrease of mature microRNAs is often observed in human malignancies giving them potential to act as tumor… 
Highly Cited
2016
Highly Cited
2016
Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Highly Cited
2015
Highly Cited
2015
Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of-Function Activities
Mutant p53 (mtp53) is an oncogene that drives cancer cell proliferation. Here we report that mtp53 associates with the promoters… 
Highly Cited
2015
Highly Cited
2015
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
Significance Mutant p53 (mtp53) is a driver oncogene of breast cancer. Here, for the first time, to our knowledge, using an… 
Highly Cited
2014
Highly Cited
2014
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
Mutations of the p53 gene hallmark many human cancers. Several p53 mutant proteins acquire the capability to promote cancer… 
Highly Cited
2014
Highly Cited
2014
Degradation of mutant p53H175 protein by Zn(II) through autophagy
TP53, one of the most important oncosuppressors, is frequently mutated in cancer. Several p53 mutant proteins escape proteolytic… 
Highly Cited
2013
Highly Cited
2013
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
The tumour suppressor p53 is frequently mutated in tumours. Mutant p53 (Mutp53) proteins often gain new activities in promoting… 
Highly Cited
2006
Highly Cited
2006
A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Mdm2 negatively regulates p53 by inhibiting its transcriptional activity and promoting its degradation by functioning as an E3… 
Highly Cited
2002
Highly Cited
2002
Prognostic value of P53 mutations in rectal carcinoma
The influence of p53 mutations on the response to ionizing radiation and survival was retrospectively evaluated in patients… 
Highly Cited
1997
Highly Cited
1997
MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells.
The murine double minute 2 (MDM2) protein facilitates G1 to S phase transition by activation of E2F-1 and can enhance cell… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)